
5-Amino-1MQ is a quinolinium analog utilized in controlled laboratory settings for the investigation of nicotinamide N-methyltransferase (NNMT) inhibition. Within research models, modulation of NNMT activity is examined for its role in nicotinamide metabolism and NAD⁺-associated cellular pathways. NNMT expression has been characterized across multiple tissue systems, with adipose, hepatic, and skeletal muscle models frequently employed due to their measurable metabolic and transcriptional outputs under defined experimental conditions.
Preclinical research, including in vitro assays and animal models, commonly evaluates how targeted NNMT inhibition influences intracellular metabolite profiles, redox balance, and gene expression signatures associated with energy regulation. Established investigative areas include adipocyte lipid metabolism, glucose transporter signaling pathways (including GLUT4-associated mechanisms), and skeletal muscle biology, where markers of stem cell activity and tissue remodeling are assessed. These model systems enable precise exploration of enzyme-dependent metabolic mechanisms in controlled laboratory environments without implying human application.
Consistent with Hanobi® standards, all materials are manufactured under rigorous quality control protocols and are verified through analytical testing to ensure identity and purity. Products are synthesized and handled exclusively for scientific research and development purposes.
Capsules are supplied solely as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any manner.
Not for use in humans or animals. Not for diagnostic or therapeutic purposes.
Kraus D et al., Nature Communications, 2014;5:4113
Kannt A et al., Biochemical Pharmacology, 2018;155:316–328
Ulanovskaya OA et al., Nature Chemical Biology, 2013;9(5):300–306